Two cancer research studies reveal essential role of neutrophils in immunotherapy

Two independent Ludwig Cancer Research studies published in the current issue of the journal Cell show that immune cells known as neutrophils, whose abundance in the microenvironment of tumors has traditionally been associated with poor patient prognosis, can play an important role in the success of cancer immunotherapies.

Surprise Finding Shows That Neutrophils Can Be Key Antitumor

ESMO 2016: Ceritinib provides longer PFS than chemo in trial of

Patients with refractory metastatic colorectal cancer experience

ASCO GI: Trifluridine/tipiracil plus bevacizumab improves OS for

Cancer discovery could revive failed treatments for solid tumours

Surprise Finding Shows That Neutrophils Can Be Key Antitumor

Stress-tolerant cells drive tumour initiation in pancreatic cancer

ESMO 2016: Pembrolizumab new option for first line treatment of

Turbocharging the killing power of immune cells against cancer

A molecular glue to overcome cancer drug resistance? - ecancer

ASCO GI: Less chemotherapy may have more benefit in rectal cancer